Canadian Cancer Society logo

Eye cancer

You are here: 

Chemotherapy for eye cancer

Chemotherapy may be used to treat eye cancer in certain situations. Chemotherapy is the use of anti-cancer (cytotoxic) drugs to treat cancer. It is usually a systemic therapysystemic therapyTreatment that travels through the bloodstream to reach cells all over the body. that circulates throughout the body and destroys cancer cells, including those that may have broken away from the primary tumour. Some types of eye cancer, such as conjunctival or eyelid tumours, may be treated with topical chemotherapytopical chemotherapyTreatment with anti-cancer drugs in a lotion, cream or ointment that can be applied to the skin. applied directly to the eye.

Chemotherapy may be used:

  • as the primary treatment, with or without radiation therapy, to destroy cancer cells
    • Most people with lymphoma of the eye will have chemotherapy.
    • Radiation therapy may also be given in combination with chemotherapy.
  • to relieve pain or to control the symptoms of advanced eye cancer (palliative chemotherapy)
    • Chemotherapy doesn’t usually work well for melanoma of the eye. It is usually only used if the intraocular melanoma is advanced or has spread (metastasized).
  • to treat recurrent eye melanoma that has come back after treatment with surgery or radiation therapy

Drugs, doses and schedules vary from person to person.

Chemotherapy drugs

Chemotherapy drugs used to treat ocular lymphoma are the same as those used to treat other types of non-Hodgkin lymphoma.

Chemotherapy drugs used to treat eye melanoma are the same as those used to treat melanoma skin cancer.

For detailed information on specific drugs, go to sources of drug information.

See a list of questions to ask your doctor about chemotherapy.


Nikki Ross Volunteering during Daffodil Month is a fun way to show your support.

Read Nikki's story

Clinical trial discovery improves quality of life

Illustration of test tubes

A clinical trial led by the Society’s NCIC Clinical Trials group found that men with prostate cancer who are treated with intermittent courses of hormone therapy live as long as those receiving continuous therapy.

Learn more